Your browser doesn't support javascript.
loading
Discontinuation Syndrome With JAK2 Selective Agents: Case Presentation and Mechanistic Insights.
Handa, Shivani; Farina, Kyle A; Becker, Michelle; Kelly, Brianna; Yu, Ashley; Feld, Jonathan; Tremblay, Douglas; Marcellino, Bridget K; Salib, Christian; Mascarenhas, John; Shih, Alan H.
Affiliation
  • Handa S; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
  • Farina KA; Department of Pharmacy Practice, The Mount Sinai Hospital, New York, NY.
  • Becker M; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
  • Kelly B; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
  • Yu A; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
  • Feld J; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
  • Tremblay D; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
  • Marcellino BK; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
  • Salib C; Department of Pathology, Molecular & Cell-Based Medicine, Icahn School of Medicine, The Mount Sinai Hospital, New York, NY.
  • Mascarenhas J; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
  • Shih AH; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
JCO Precis Oncol ; 8: e2300234, 2024 Jan.
Article de En | MEDLINE | ID: mdl-38295318
ABSTRACT
We report the first case of pacritinib-withdrawal syndrome with in vitro elucidation of underlying mechanisms.
Sujet(s)

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Myélofibrose primitive Limites: Humans Langue: En Journal: JCO Precis Oncol Année: 2024 Type de document: Article

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Myélofibrose primitive Limites: Humans Langue: En Journal: JCO Precis Oncol Année: 2024 Type de document: Article